2Bruix J,Levesque H. Prevalence of antibodies to hepatitis C Virus in Spanish patients with hepatocellalor carcinoma and hepatic cirrhosis. Lancet .1989,2:1004.
3Colombo M,Horslev PK, Laurent AE, et al. Prevalence of antiboties to hepatitis C virus in Spanish patients with hepatocellular carcinoma. Lancet .1989,2:1006.
4刘树林，中华医学杂志，1986年，66卷，413页
5任红，中华医学杂志，1989年，69卷，264页
6苗德林，中华病理学杂志，1985年，14卷，176页
7骆抗先.乙型肝炎的基础与临床[M].北京:人民卫生出版社,1997.115.
8Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol,2000, 190(4):412-416.
9Kim KY ,Jeong SY, Won J,et al. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.J Biol Chem, 2001,276(42):38781-38786.
10Akiba J,Yano H,Ogasawara S, et al. Expression and function of interleulin-8 in human hepatocellular carcinoma. Int J Oncol, 2001,18(2):257-264.
